June 9, 2025 Delivering regulatory impact from consortium-based projects Multiple consortia have been established in the past two decades with the aim of tackling roadblocks in the development of...
May 27, 2025 C-Path Welcomes Avidity Biosciences as Newest Member to Duchenne Consortium C-Path is excited to welcome Avidity Biosciences as a new member of the Duchenne Regulatory Science Consortium (D-RSC). Avidity is
May 15, 2025 From Awareness to Action: How C-Path’s HD-RSC Is Transforming the Future of Huntington’s Disease May 15, marks Huntington’s Disease Awareness Day, a key moment during Huntington’s Awareness...
May 22, 2025 RDCA-DAP and NORD’s IAMRARE Platform to Platform Federation: Lessons Learned Patient data is a key asset in understanding the progression of rare diseases...
April 28, 2025 Lysosomal Storage Disease Data Sharing Webinar Series – Session #3: Retroactive Data Sharing The recent webinar from C-Path’s Critical Path for Lysosomal Diseases (CPLD) team focused on the critical issue of retroacti
April 25, 2025 C-Path’s Stephenson Featured in BioCentury Article C-Path Vice President of Neurology and Executive Director of Critical Path for Parkinson's (CPP) Consortium...
April 9, 2025-April 10, 2025 2025 Clinical Outcome Assessment Program Annual Meeting On April 9-10, 2025, the 2025 Clinical Outcome Assessment...
April 11, 2025 2025 Clinical Outcome Assessment Program Annual Meeting Recap On April 9-10, 2025, the 2025 Clinical Outcome Assessment...
April 11, 2025 C-Path Launches Newest Podcast Episode: Connecting the Dots Between T1D and Parkinson’s In our latest episode of the C-Path podcast, “Connecting the Dots Between Type 1 Diabetes and Parkinson’s Disease,” we...
April 2, 2025 C-Path’s Stephenson Appears on Xtalks’ Life Science Podcast to Talk Future of Drug Development in Parkinson’s, Alzheimer’s C-Path's Diane Stephenson recently appeared on the Xtalks Life Science Podcast...
